organisation current research and strategies 2011 - 2012 - eortc

organisation current research and strategies 2011 - 2012 - eortc

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects

JCM, Free Full-Text

In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management

tm2225606d1_ex99-1img003.jpg

Quality of life scores according to EORTC QLQ-CR29, structure and

Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma

European Organization for Research and Treatment of Cancer Quality of

NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 11 (2022)

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12

Two mega-corrections for Anil Potti in the Journal of Clinical Oncology – Retraction Watch